JP2013521273A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013521273A5 JP2013521273A5 JP2012555537A JP2012555537A JP2013521273A5 JP 2013521273 A5 JP2013521273 A5 JP 2013521273A5 JP 2012555537 A JP2012555537 A JP 2012555537A JP 2012555537 A JP2012555537 A JP 2012555537A JP 2013521273 A5 JP2013521273 A5 JP 2013521273A5
- Authority
- JP
- Japan
- Prior art keywords
- done
- maximum
- diffraction spectrum
- milling method
- ray spectral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 1
- 229960003040 rifaximin Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A000370 | 2010-03-05 | ||
| ITMI2010A000370A IT1398550B1 (it) | 2010-03-05 | 2010-03-05 | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| PCT/IB2011/050933 WO2011107970A2 (en) | 2010-03-05 | 2011-03-04 | Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013521273A JP2013521273A (ja) | 2013-06-10 |
| JP2013521273A5 true JP2013521273A5 (https=) | 2014-01-30 |
| JP5932669B2 JP5932669B2 (ja) | 2016-06-08 |
Family
ID=42697389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012555537A Expired - Fee Related JP5932669B2 (ja) | 2010-03-05 | 2011-03-04 | リファキシミン粉体、その調製方法、及び長期持続効果を得るために有用な前記リファキシミン含有徐放性組成物 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8748447B2 (https=) |
| EP (1) | EP2542225B1 (https=) |
| JP (1) | JP5932669B2 (https=) |
| KR (1) | KR101663491B1 (https=) |
| CN (1) | CN102781432B (https=) |
| AU (1) | AU2011222432B2 (https=) |
| BR (1) | BR112012021681A8 (https=) |
| CA (1) | CA2787123C (https=) |
| CL (1) | CL2012002124A1 (https=) |
| CO (1) | CO6551760A2 (https=) |
| DK (1) | DK2542225T3 (https=) |
| EA (1) | EA022324B1 (https=) |
| ES (1) | ES2496771T3 (https=) |
| HR (1) | HRP20140876T1 (https=) |
| IL (1) | IL220792A (https=) |
| IT (1) | IT1398550B1 (https=) |
| MX (1) | MX2012010233A (https=) |
| NZ (1) | NZ602230A (https=) |
| PL (1) | PL2542225T3 (https=) |
| PT (1) | PT2542225E (https=) |
| RS (1) | RS53609B1 (https=) |
| SG (1) | SG182523A1 (https=) |
| SI (1) | SI2542225T1 (https=) |
| TN (1) | TN2012000362A1 (https=) |
| UA (1) | UA107208C2 (https=) |
| WO (1) | WO2011107970A2 (https=) |
| ZA (1) | ZA201205537B (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1698630E (pt) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais |
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| WO2011080691A1 (en) | 2009-12-28 | 2011-07-07 | Silvio Massimo Lavagna | Method for the production of amorphous rifaximin |
| IT1398550B1 (it) * | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| AU2011225810B2 (en) * | 2010-03-10 | 2014-11-06 | Lupin Limited | Rifaximin ready-to-use suspension |
| ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| ITBO20120368A1 (it) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso. |
| US9849090B2 (en) | 2012-12-12 | 2017-12-26 | Sun Pharmaceutical Industries Limited | Pharmaceutical compositions of rifaximin |
| US10572631B2 (en) | 2014-08-01 | 2020-02-25 | Bioxcel Corporation | Methods for reformulating and repositioning pharmaceutical data and devices thereof |
| WO2016063289A2 (en) * | 2014-10-22 | 2016-04-28 | Strides Arcolab Limited | Pharmaceutical tablet compositions comprising rifaximin |
| BR112017016393A2 (pt) * | 2015-05-08 | 2018-03-27 | Wockhardt Limited | composições farmacêuticas estáveis compreendendo agente antibacteriano |
| TR201909029T4 (tr) | 2016-03-24 | 2019-07-22 | Sandoz Ag | Rifaksimin alfa içeren saklanmaya yönelik kararlı bileşimler. |
| WO2017162725A1 (en) | 2016-03-24 | 2017-09-28 | Sandoz Ag | Pharmaceutical composition containing rifaximin alpha & delta |
| PT3518924T (pt) | 2016-09-30 | 2022-10-27 | Salix Pharmaceuticals Inc | Formas de dispersão sólidas de rifaximina |
| WO2020208140A1 (en) * | 2019-04-12 | 2020-10-15 | Sandoz Ag | Rifaximin-containing granules |
| WO2023067485A1 (en) * | 2021-10-19 | 2023-04-27 | Zydus Lifesciences Limited | Pharmaceutical combinations |
| WO2025170483A1 (ru) * | 2024-02-07 | 2025-08-14 | Общество с ограниченной ответственностью "БИННОФАРМ ГРУПП" | Фармацевтическая композиция, обладающая антибиотической активностью |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
| DE3113139A1 (de) | 1981-04-01 | 1982-10-21 | Smit Transformatoren B.V., 6500 Nijmegen | "trockentransformator oder drosselspule mit luftkuehlung" |
| IT1199374B (it) | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
| US5356625A (en) | 1986-08-28 | 1994-10-18 | Enzacor Properties Limited | Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| GB8816620D0 (en) | 1988-07-13 | 1988-08-17 | Lepetit Spa | Rifapentine hydrohalides |
| DK0536197T3 (da) | 1990-06-29 | 1995-11-13 | Lepetit Spa | Ren, krystallinsk form af rifapentine |
| IT1253711B (it) | 1991-12-17 | 1995-08-23 | Alfa Wassermann Spa | Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali |
| IT1264494B1 (it) | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
| EP0935417B1 (en) | 1996-10-16 | 2009-05-06 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| IT1290679B1 (it) | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
| US20030059471A1 (en) | 1997-12-15 | 2003-03-27 | Compton Bruce Jon | Oral delivery formulation |
| US20030157174A1 (en) | 2000-03-23 | 2003-08-21 | Takayuki Tsukuda | Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component |
| US20040170617A1 (en) | 2000-06-05 | 2004-09-02 | Finegold Sydney M. | Method of treating diseases associated with abnormal gastrointestinal flora |
| UA75365C2 (en) | 2000-08-16 | 2006-04-17 | Bristol Myers Squibb Co | Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon |
| PL361912A1 (en) | 2000-10-31 | 2004-10-04 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of venlafaxine hydrochloride |
| IL156055A0 (en) | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
| US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| US7902206B2 (en) | 2003-11-07 | 2011-03-08 | Alfa Wassermann, S.P.A. | Polymorphic forms α, β and γ of rifaximin |
| ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
| US7923553B2 (en) | 2003-11-07 | 2011-04-12 | Alfa Wassermann, S.P.A. | Processes for the production of polymorphic forms of rifaximin |
| US20080262024A1 (en) | 2003-11-07 | 2008-10-23 | Giuseppe Claudio Viscomi | Rifaximin compositions and method of use |
| US7906542B2 (en) | 2004-11-04 | 2011-03-15 | Alfa Wassermann, S.P.A. | Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin |
| US20050196418A1 (en) | 2004-03-04 | 2005-09-08 | Yu Ruey J. | Bioavailability and improved delivery of alkaline pharmaceutical drugs |
| PT1698630E (pt) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais |
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| ITMI20061692A1 (it) | 2006-09-05 | 2008-03-06 | Alfa Wassermann Spa | Uso di polioli per ottenere forme polimorfe stabili di rifaximina |
| KR101667534B1 (ko) * | 2006-09-22 | 2016-10-19 | 씨아이피엘에이 엘티디. | 리팍시민 |
| ITMI20071241A1 (it) * | 2007-06-20 | 2008-12-21 | Solmag S P A | Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta |
| WO2009008006A2 (en) | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
| JP5755878B2 (ja) | 2007-07-06 | 2015-07-29 | ルパン リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ | リファキシミンの薬剤組成物 |
| EP2011486B2 (en) | 2007-07-06 | 2015-08-12 | Lupin Ltd. | Pharmaceutical compositions of rifaximin |
| US7709634B2 (en) * | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
| US8486956B2 (en) | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
| UA113275C2 (xx) | 2008-02-25 | 2017-01-10 | ζ-ФОРМА РИФАКСИМІНУ І ЇЇ ЗАСТОСУВАННЯ | |
| WO2010044093A1 (en) | 2008-10-16 | 2010-04-22 | Strides Arcolab Limited | Formulations containing rifaximin |
| ES2718614T3 (es) | 2008-12-10 | 2019-07-03 | Cipla Ltd | Complejos de rifaximina |
| IT1397617B1 (it) | 2009-04-20 | 2013-01-18 | Alfa Wassermann Spa | Nuovi derivati della rifamicina |
| PT2493471T (pt) | 2009-10-26 | 2020-01-09 | Borody Thomas J | Nova terapia de combinação entérica |
| MY177151A (en) | 2009-10-27 | 2020-09-08 | Lupin Ltd | Solid dispersion of rifaximin |
| WO2011061748A1 (en) | 2009-11-19 | 2011-05-26 | Strides Arcolab Limited | Rifaximin premix |
| US20130202654A1 (en) | 2009-11-23 | 2013-08-08 | Cipla Limited | Topical Foam Composition |
| RU2012126084A (ru) | 2009-11-23 | 2013-12-27 | Сипла Лимитед | Пенная композиция для местного применения |
| WO2011080691A1 (en) | 2009-12-28 | 2011-07-07 | Silvio Massimo Lavagna | Method for the production of amorphous rifaximin |
| CN101773465B (zh) | 2010-01-19 | 2012-11-07 | 南京泛太化工医药研究所 | 以氨基酸为稳定剂的聚合物胶束载药系统 |
| IT1398550B1 (it) * | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| AU2011225810B2 (en) | 2010-03-10 | 2014-11-06 | Lupin Limited | Rifaximin ready-to-use suspension |
| EA022490B1 (ru) | 2010-06-03 | 2016-01-29 | Саликс Фармасьютикалс, Лтд. | Новые формы рифаксимина и их применение |
| CA2802874A1 (en) | 2010-06-16 | 2011-12-22 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
| ES2801678T3 (es) | 2010-07-12 | 2021-01-12 | Salix Pharmaceuticals Inc | Formulaciones de rifaximina y sus usos |
| MX2013002802A (es) | 2010-09-13 | 2013-06-03 | Cipla Ltd | Composicion farmaceutica. |
| WO2012035544A2 (en) | 2010-09-13 | 2012-03-22 | Sequent Scientific Ltd. | A novel polymorphic form of rifaximin and process for its preparation |
| IT1403847B1 (it) | 2010-09-22 | 2013-11-08 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina e loro uso. |
| WO2012076832A1 (en) | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
| SG192122A1 (en) | 2011-02-11 | 2013-08-30 | Salix Pharmaceuticals Ltd | Forms of rifaximin and uses thereof |
| WO2012150561A1 (en) | 2011-05-02 | 2012-11-08 | Ranbaxy Laboratories Limited | Rifaximin dimethylformamide solvate |
| ITMI20110890A1 (it) | 2011-05-19 | 2012-11-20 | A M S A Anonima Materie Sint & Affini S P A | Polimorfo di rifaximina e processo per la sua preparazione |
| ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| CA2876737A1 (en) | 2012-06-13 | 2013-12-19 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
| US9849090B2 (en) | 2012-12-12 | 2017-12-26 | Sun Pharmaceutical Industries Limited | Pharmaceutical compositions of rifaximin |
| ITMI20131307A1 (it) | 2013-08-02 | 2015-02-02 | A M S A Anonima Materie Sint & Affini S P A | Processo per la preparazione di refaximina k |
-
2010
- 2010-03-05 IT ITMI2010A000370A patent/IT1398550B1/it active
-
2011
- 2011-03-04 ES ES11714663.9T patent/ES2496771T3/es active Active
- 2011-03-04 SI SI201130298T patent/SI2542225T1/sl unknown
- 2011-03-04 EA EA201290734A patent/EA022324B1/ru unknown
- 2011-03-04 HR HRP20140876AT patent/HRP20140876T1/hr unknown
- 2011-03-04 AU AU2011222432A patent/AU2011222432B2/en not_active Ceased
- 2011-03-04 DK DK11714663.9T patent/DK2542225T3/da active
- 2011-03-04 CA CA2787123A patent/CA2787123C/en active Active
- 2011-03-04 EP EP11714663.9A patent/EP2542225B1/en active Active
- 2011-03-04 PL PL11714663T patent/PL2542225T3/pl unknown
- 2011-03-04 JP JP2012555537A patent/JP5932669B2/ja not_active Expired - Fee Related
- 2011-03-04 MX MX2012010233A patent/MX2012010233A/es unknown
- 2011-03-04 US US13/582,676 patent/US8748447B2/en active Active
- 2011-03-04 PT PT117146639T patent/PT2542225E/pt unknown
- 2011-03-04 RS RS20140619A patent/RS53609B1/sr unknown
- 2011-03-04 KR KR1020127022961A patent/KR101663491B1/ko not_active Expired - Fee Related
- 2011-03-04 NZ NZ602230A patent/NZ602230A/xx not_active IP Right Cessation
- 2011-03-04 CN CN201180012550.XA patent/CN102781432B/zh not_active Expired - Fee Related
- 2011-03-04 SG SG2012051975A patent/SG182523A1/en unknown
- 2011-03-04 WO PCT/IB2011/050933 patent/WO2011107970A2/en not_active Ceased
- 2011-03-04 BR BR112012021681A patent/BR112012021681A8/pt not_active Application Discontinuation
- 2011-04-03 UA UAA201208484A patent/UA107208C2/uk unknown
-
2012
- 2012-07-05 IL IL220792A patent/IL220792A/en active IP Right Grant
- 2012-07-17 TN TNP2012000362A patent/TN2012000362A1/en unknown
- 2012-07-23 ZA ZA2012/05537A patent/ZA201205537B/en unknown
- 2012-07-30 CO CO12127400A patent/CO6551760A2/es not_active Application Discontinuation
- 2012-07-31 CL CL2012002124A patent/CL2012002124A1/es unknown
-
2014
- 2014-04-24 US US14/261,337 patent/US9498442B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013521273A5 (https=) | ||
| ZA201107806B (en) | Organisms for the production of 1,3-butanediol | |
| AP2014007436A0 (en) | A novel 1,2,3,4,-Tetrahydroquinoline derivative useful for the treatment of diabetes | |
| JP2014102408A5 (https=) | ||
| JP2012190484A5 (https=) | ||
| JP2012081521A5 (https=) | ||
| JP2013532130A5 (https=) | ||
| EP2699091A4 (en) | 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS | |
| GB2485667B (en) | Controlling hydrogen-deuterium exchange on a spectrum by spectrum basis | |
| JP2012035359A5 (https=) | ||
| IL216935A (en) | Process for making if the pearl is mechanically designed by mechanical synthesis, if the pearl is designed so mechanically and applied | |
| EP2760812B8 (en) | Process for producing 2,3,3,3-tetrafluoropropene | |
| MX2013013463A (es) | Nuevo procedimiento para la síntesis de rifaximina y una nueva forma pseudocristalina de rifaximina obtenida con el mismo. | |
| JP2013528272A5 (https=) | ||
| JP2011234359A5 (https=) | ||
| PH12015502122A1 (en) | Sovaprevir polymorphs and methods of manufacturing thereof | |
| WO2015022265A3 (en) | Cyclobutyl carboxamides as nematicides | |
| EP2687520A4 (en) | PROCESS FOR PREPARING A 1,2-BENZISOTHIAZOL-3-ON COMPOUND | |
| IL232194A0 (en) | An improved iontophoretic cross-linking mixture for use in the treatment of keratoconus | |
| EP2687519A4 (en) | PROCESS FOR PRODUCING 1,2-BENZISOTHIAZOL-3-ONE COMPOUNDS | |
| EP2883870B8 (en) | Method for producing 1,4-benzoxazine compound | |
| WO2016016774A8 (en) | Crystalline forms of canagliflozin | |
| WO2013001352A3 (en) | Synthesis of cleistanthin a an derivatives thereof | |
| JP2013531183A5 (https=) | ||
| JP2014507254A5 (https=) |